Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$3.49 USD
+0.08 (2.35%)
Updated Aug 29, 2024 04:00 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Shattuck Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 131 | 161 | 269 | 335 | 39 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 13 | 23 | 19 | 10 | 3 |
Total Current Assets | 143 | 185 | 288 | 346 | 42 |
Net Property & Equipment | 14 | 18 | 10 | 3 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 3 | 3 | 0 | 0 | 0 |
Total Assets | 160 | 205 | 299 | 349 | 45 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 7 | 10 | 2 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 10 | 18 | 15 | 7 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 8 | 13 |
Total Current Liabilities | 11 | 25 | 25 | 17 | 20 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 2 | 22 | 10 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 15 | 29 | 27 | 39 | 30 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 49 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 451 | 396 | 389 | 382 | 1 |
Retained Earnings | -306 | -219 | -117 | -72 | -35 |
Other Equity | 0 | -1 | -1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 145 | 176 | 272 | 310 | 15 |
Total Liabilities & Shareholder's Equity | 160 | 205 | 299 | 349 | 45 |
Total Common Equity | 145 | 176 | 272 | 310 | -35 |
Shares Outstanding | 42.40 | 42.30 | 42.20 | 41.70 | NA |
Book Value Per Share | 3.41 | 4.16 | 6.44 | 7.43 | 0.00 |
Fiscal Year End for Shattuck Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 105 | 115 | 131 | 101 | 117 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 9 | 16 | 13 | 12 | 19 |
Total Current Assets | 114 | 131 | 143 | 113 | 136 |
Net Property & Equipment | 12 | 13 | 14 | 15 | 16 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 2 | 3 | 3 | 3 |
Total Assets | 129 | 146 | 160 | 130 | 155 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 2 | 2 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 8 | 10 | 12 | 11 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 5 | 0 | 0 | 0 |
Total Current Liabilities | 15 | 14 | 11 | 14 | 13 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 18 | 18 | 15 | 18 | 17 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 457 | 454 | 451 | 401 | 400 |
Retained Earnings | -346 | -325 | -306 | -289 | -261 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 111 | 129 | 145 | 113 | 138 |
Total Liabilities & Shareholder's Equity | 129 | 146 | 160 | 130 | 155 |
Total Common Equity | 111 | 129 | 145 | 113 | 138 |
Shares Outstanding | 47.70 | 47.50 | 42.40 | 42.40 | 42.40 |
Book Value Per Share | 2.32 | 2.71 | 3.41 | 2.66 | 3.27 |